Pacala Mark L (CIK 1321250) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-29). Recent activity: Buy TOI (30,120 shares), Buy TOI (46,296 shares), Buy TOI (35,494 shares), Sell TOI (2,160 shares), Sell TOI (1,210 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-29 | Oncology Institute, Inc. (TOI) | Director | Buy | 30,120 | $0 |
| 2025-11-24 | Oncology Institute, Inc. (TOI) | Director | Buy | 46,296 | $0 |
| 2025-11-24 | Oncology Institute, Inc. (TOI) | Director | Buy | 35,494 | $0 |
| 2025-11-20 | Oncology Institute, Inc. (TOI) | Director | Sell | 2,160 | $8,640 |
| 2025-11-20 | Oncology Institute, Inc. (TOI) | Director | Sell | 1,210 | $4,840 |
| 2025-11-20 | Oncology Institute, Inc. (TOI) | Director | Sell | 46,630 | $186,520 |
| 2025-03-28 | Oncology Institute, Inc. (TOI) | Director | Buy | 90,562 | $94,184 |
Source: SEC Form 4 filings · as of 2026-07-29